Sexual health and needs for sexology care in digestive cancer patients undergoing chemotherapy: a 4-month cross-sectional study in a French University Hospital
To assess sexual health and needs for sexology care of cancer patients during chemotherapy.
We performed a 4-month cross-sectional study in cancer patients treated by chemotherapy in the digestive cancer department of a regional university hospital. Patients were asked to fill out a self-administered questionnaire about their sexual health, Sexual Quality of Life Questionnaire for Male (SQoL-M) or Female (SQoL-F), and their needs for sexology care.
The study sample was composed of 47 men and 31 women. Tumor locations were 36 colorectal (46%), 23 pancreatic (30%), and 19 other digestive cancers (24%). SQoL scores were lower in women (p < .001), in pancreatic and colorectal tumors (p = .041 and p = .033, respectively) compared to other digestive cancers, and in less-educated patients (p = .023). During chemotherapy, 40% of sexually active patients had less frequent sexual intercourse than before diagnosis, and 33% had completely stopped sexual activity. Sexuality care was desired by 44% of respondents. Among them, 83% favored a consultation with a medical sexologist and 63% with a psycho-sexologist, 54% wanted couple therapy, and 31% considered support groups. Patients with colorectal cancer had more frequent sexual intercourse without penetration at the time of survey (p = .036) and more often wanted couple therapy than patients with pancreatic cancer (p = .048).
This study is the first determination of sexual health and sexual quality of life in digestive cancers. Targets for interventions during chemotherapy for digestive cancers include populations with lower sexual quality of life: women, pancreatic sites, patients with sexual troubles during chemotherapy, and less-educated patients.
KeywordsOncosexology Sexual health Chemotherapy Digestive cancer Quality of life Supportive care
We gratefully acknowledge Dr. Deslandres Marion and Dr. Anne-Pascale Laurenty for their valuable insights for implementing this study and particularly the oncology teams of the Digestive Cancer Department who helped in the recruitment.
Compliance with ethical standards
Each patient was given a verbal explanation of the study by TA and signed a written informed consent. The study was approved by the French Advisory Committee for Data Processing in Health Research (CCTIRS) under the number 16.037.
Conflict of interest
The study was methodologically supported by the University Cancer Center of Toulouse (University Hospital of Rangueil), the Cancer Network of Midi-Pyrénées (ONCOMIP), the Association of Coordinators of the French Cancer Networks (ACORESCA), the joint group of the Federative Group of French Cancer Centers (UNICANCER) and the French Association for Supportive Care (AFSOS), and the French Education and Research Group of Andrology, Urology, and Sexology (GEFRAUS).
This project was granted by the French National League Against Cancer (PhD grant no. TDTJ12441 — 2013e2016). The authors report having no financial relationship with the organization that sponsored the research. The authors also declare having full control of all primary data and agree to allow the journal to review their data if requested.
- 3.National Health Institute (2006) The prevalence and types of sexual dysfunction in people with cancer. https://www.cancer.gov. Accessed 13 June 2012
- 6.Le Corroller-Soriano AG, Malavolti L, Mermilliod C (2008) La vie deux ans après le diagnostic de cancer, La Documentation Française edn. DRESS, INSERM: Collection Etudes et Statistiques, ParisGoogle Scholar
- 7.Institut National du Cancer (2014) La vie deux ans après un diagnostic de cancer - De l’annonce à l’après cancer. http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/La-vie-deux-ans-apres-un-diagnostic-de-cancer-De-l-annonce-a-l-apres-cancer
- 10.Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW, Paraskevas P, Clark SK, Tekkis PP (2007) The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 50(8):1128–1138. https://doi.org/10.1007/s10350-007-0240-7 CrossRefPubMedGoogle Scholar
- 11.Lange MM, Marijnen CA, Maas CP, Putter H, Rutten HJ, Stiggelbout AM, Meershoek-Klein Kranenbarg E, van de Velde CJ, Cooperative clinical investigators of the D (2009) Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 45(9):1578–1588. https://doi.org/10.1016/j.ejca.2008.12.014 CrossRefPubMedGoogle Scholar
- 17.Habold D, Farsi F (2012) Cancer, santé sexualité et intimité. Référentiel AFSOS. http://www.afsos.org/wp-content/uploads/2016/09/Cancer_vie_et_sante_sexuelle.pdf. Accessed 17 Jan 2017
- 18.Chen RC, Clark JA, Talcott JA (2009) Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol 27(24):3916–3922. https://doi.org/10.1200/JCO.2008.18.6486 CrossRefPubMedGoogle Scholar
- 19.Almont T, Delannes M, Ducassou A, Corman A, Bondil P, Moyal E, Schover L, Eric H (2017) Sexual quality of life and needs for sexual care of cancer patients admitted for radiotherapy: a 3-month cross-sectional study. J Sex Med 14(4):566–576. https://doi.org/10.1016/j.jsxm.2017.02.013 CrossRefPubMedGoogle Scholar
- 24.Letourneau JM, Smith JF, Ebbel EE, Craig A, Katz PP, Cedars MI, Rosen MP (2012) Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer 118(18):4579–4588. https://doi.org/10.1002/cncr.26649 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Pezzilli R, Falconi M, Zerbi A, Casadei R, Valli L, Varale R, Armatura G, Felicani C, Morselli-Labate AM (2011) Clinical and patient-reported outcomes after pancreatoduodenectomy for different diseases: a follow-up study. Pancreas 40(6):938–945. https://doi.org/10.1097/MPA.0b013e318216f693 CrossRefPubMedGoogle Scholar
- 33.Anwar S, Tan W, Yu J, Hutson A, Javle M, Iyer R (2014) Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial. J Gastrointest Oncol 5(6):433–439. https://doi.org/10.3978/j.issn.2078-6891.2014.070 PubMedPubMedCentralGoogle Scholar
- 36.Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M (2007) A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 100(4):858–862. https://doi.org/10.1111/j.1464-410X.2007.07161.x CrossRefPubMedGoogle Scholar
- 38.Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, Chien AJ, Park JW, Rugo HS (2017) Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol 3(3):313–319. https://doi.org/10.1001/jamaoncol.2016.3904 CrossRefPubMedGoogle Scholar
- 39.Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Bober SL, Kereakoglow S, Borges VF, Come SE, Schapira L, Partridge AH (2014) Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer 120(15):2264–2271. https://doi.org/10.1002/cncr.28738 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Hall AE, Boyes AW, Bowman J, Walsh RA, James EL, Girgis A (2012) Young adult cancer survivors’ psychosocial well-being: a cross-sectional study assessing quality of life, unmet needs, and health behaviors. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 20(6):1333–1341. https://doi.org/10.1007/s00520-011-1221-x CrossRefGoogle Scholar
- 42.McCallum M, Lefebvre M, Jolicoeur L, Maheu C, Lebel S (2012) Sexual health and gynecological cancer: conceptualizing patient needs and overcoming barriers to seeking and accessing services. J Psychosom Obstet Gynaecol 33(3):135–142. https://doi.org/10.3109/0167482X.2012.709291 CrossRefPubMedGoogle Scholar